English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/143171
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Biotensegrity of the extracellular matrix: Physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy

AuthorsTadeo, Irene; Berbegall, Ana P.; Escudero, Luis M. ; Álvaro, Tomás; Noguera, Rosa
KeywordsBiotensegrity
Cancer
Neuroblastoma
Mechanotherapy
Extracellular matrix
Issue Date4-Mar-2014
PublisherFrontiers Media
CitationFrontiers in Oncology 4: article 39 (2014)
AbstractCells have the capacity to convert mechanical stimuli into chemical changes. This process is based on the tensegrity principle, a mechanism of tensional integrity. To date, this principle has been demonstrated to act in physiological processes such as mechanotransduction and mechanosensing at different scales (from cell sensing through integrins to molecular mechanical interventions or even localized massage). The process involves intra- and extracellular components, including the participation of extracellular matrix (ECM) and microtubules that act as compression structures, and actin filaments which act as tension structures. The nucleus itself has its own tensegrity system which is implicated in cell proliferation, differentiation, and apoptosis. Despite present advances, only the tip of the iceberg has so far been uncovered regarding the role of ECM compounds in influencing biotensegrity in pathological processes. Groups of cells, together with the surrounding ground substance, are subject to different and specific forces that certainly influence biological processes. In this paper, we review the current knowledge on the role of ECM elements in determining biotensegrity in malignant processes and describe their implication in therapeutic response, resistance to chemo- and radiotherapy, and subsequent tumor progression. Original data based on the study of neuroblastic tumors will be provided. © 2014 Tadeo, Berbegall, Escudero, Álvaro and Noguera.
Publisher version (URL)http://doi.org/10.3389/fonc.2014.00039
URIhttp://hdl.handle.net/10261/143171
DOI10.3389/fonc.2014.00039
Identifiersissn: 2234-943X
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
extracellular_matrix_Tadeo.pdf3,14 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.